Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »

2/141 von 416 DIMDI: MEDLINE (ME60) © NLM

ND: | ME15344672
PMID: | 15344672
LR: | 20051116
CED: | 20040903
DCO: | 20041102
Autoren: | Biggee BA; McAlindon T
Titel: | Glucosamine for osteoarthritis: part I, review of the clinical evidence.
Quelle: | Medicine and health, Rhode Island; VOL: 87 (6); p. 176-9 /200406/
PM: | Print
SU: | IM
Sprache: | English
CY: | United States
JID: | 9603446
ISSN: | 1086-5462
Institution: | Tufts-New England Medical Center, Boston, MA 02111, USA. bbiggee@tufts-nemc.org
DT: | Journal Article; Review
RN: | 28
Schlagwörter
CT: | CLINICAL TRIALS; DIETARY SUPPLEMENTS/*; GLUCOSAMINE/*therapeutic use; HUMANS; OSTEOARTHRITIS/*drug therapy
CTG: | KLINISCHE STUDIEN; NAHRUNGSERGÄNZUNGSMITTEL/*; GLUCOSAMIN/*therapeutische Anwendung; MENSCH; OSTEOARTHROSE/*Arzneimitteltherapie
TE: | Glucosamine/3416-24-8
CR: | 3416-24-8
AB: | Glucosamine is a popular nutritional supplement for OA. This supplement has shown moderate efficacy in meta-analysis and large industry-sponsored clinical trials. However, smaller independent studies have not shown significant benefit. It is difficult to compare these clinical trials due to heterogeneity in trial design, differences in glucosamine products, and differences in osteoarthritic populations being studied. The National Center for Complementary and Alternative Medicine and the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS/NCCAM) have funded a multicenter five arm placebo controlled study called The Glucosamine Arthritis Intervention Trial (GAIT). GAIT spans 24 weeks, enrolling 1588 subjects, at 13 centers comparing the efficacy of glucosamine sulfate, chondroitin sulfate, glucosamine with chondroitin, to placebo and compared to celecoxib for knee OA. This study may have final data in March 2005.

» Volltext »
» Fenster schließen »